Skip to content

Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)

Coronary Atherosclerosis Evaluation by Arterial Wall MRI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00353795
Enrollment
179
Registered
2006-07-19
Start date
2005-07-31
Completion date
2008-06-30
Last updated
2010-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis, Coronary, Atherosclerosis, Coronary, Coronary Arteriosclerosis, Coronary Artery Disease, Coronary Atherosclerosis

Keywords

MESA, MRI, Cardiovascular, Cardiac, Coronary, Atherosclerosis

Brief summary

The overall goal of this study is to use MRI to: * Examine the relationship between known risk factors for cardiovascular disease and coronary artery wall thickness; * Examine the relationship between coronary artery wall thickness and other markers of subclinical coronary atherosclerosis, such as carotid wall thickness and coronary calcium scores; and, * Examine the feasibility of measuring the progression of coronary artery wall thickness over time in a subset of participants.

Detailed description

Each enrolled participant will undergo MR Imaging of the coronary arteries in conjunction with their routine MESA follow-up visit. The MRI will last approximately 45-60 minutes

Interventions

PROCEDUREMR Imaging of the Coronary Arteries

Sponsors

Northwestern University
CollaboratorOTHER
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Prior enrollment in the MESA Study at the Hopkins MESA Field Center or the Northwestern University MESA Field Center * Male or Female adult equal to or older than 45 years of age * Willing/able to provide informed consent

Exclusion criteria

* Any known contraindications to MRI (i.e. severe claustrophobia, pacemaker, etc.) * Metal in the eyes

Design outcomes

Primary

MeasureTime frameDescription
Mean Coronary Wall Thicknessn/a (cross sectional analysis)Average thickness of the wall of the left anterior descending, right and left main coronary artery measured by magnetic resonance imaging (MRI).

Countries

United States

Participant flow

Participants by arm

ArmCount
Participants
Participants in the MESA trial (http://www.mesa-nhlbi.org/) randomly selected by the University of Washington Coordinating center who agreed to participate. Enrollment from October 2005 to February 2008
179
Total179

Baseline characteristics

CharacteristicParticipants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
179 Participants
Age Continuous61 years
STANDARD_DEVIATION 9
Region of Enrollment
United States
179 participants
Sex: Female, Male
Female
90 Participants
Sex: Female, Male
Male
89 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 179
serious
Total, serious adverse events
0 / 179

Outcome results

Primary

Mean Coronary Wall Thickness

Average thickness of the wall of the left anterior descending, right and left main coronary artery measured by magnetic resonance imaging (MRI).

Time frame: n/a (cross sectional analysis)

ArmMeasureValue (MEAN)Dispersion
ParticipantsMean Coronary Wall Thickness2.0 mmStandard Deviation 0.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026